Treatment of adult men with metastatic hormone-sensitive prostate cancer (mHSPC) in combination with androgen deprivation therapy.
Treatment of adults with metastatic hormone-sensitive prostate cancer (mHSPC) in combination with docetaxel
For the treatment of adult men with non-metastatic castration resistant prostate cancer who are at high risk of developing metastatic disease.
No medicines have been found.
